Tradestie Institutional Equity Comparison Engine

ZGM vs SBC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SBC Overall Edge

SBC Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SBC Medical Group Holdings Incorporated Common Stock (SBC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, ZGM trades at N/M Forward P/E with 31.7% operating margin (-27.0% YoY revenue) versus SBC at 9.0x Forward P/E and 39.9% operating margin (+35.1% YoY). In options structure, ZGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SBC
ZGM N/M vs SBC 9.0x Fwd P/E
Growth & Margin Winner SBC
Op Margin 31.7% vs 39.9% ยท YoY -27.0% vs +35.1%
Momentum & Technical Winner SBC
1Y -55.3% vs +63.6% ยท 52W Pos 16% vs 52%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ZGM NASDAQ
Zenta Group Company Limited Ordinary Shares
Services-Management Consulting Services
$1.65
+7.14% 1D
Market Cap $18.2M
1M Return -10.81%
1Y Return -55.28%
Forward P/E N/M
Unified AI Score
59.4 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0
SBC NASDAQ
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.17
-7.68% 1D
Market Cap $574.4M
1M Return -9.14%
1Y Return +63.61%
Forward P/E 9.0x
Unified AI Score
47.2 / 100 HOLD
Tech 41.0 Fund 36.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZGM -55.28% SBC +63.61% Spread: +59.69 pp (SBC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZGM TTM Op. Margin: 31.7% SBC TTM Op. Margin: 39.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZGM vs SBC. Trailing 12-month operating profitability (ZGM 31.7% vs SBC 39.9%) and valuation multiples (ZGM N/M vs SBC 9.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZGM (3) vs SBC (7)
Institutional Metric ZGM SBC Criterion Row Winner
Market Capitalization Scale $18.2M $574.4M Larger Scale SBC
Trailing P/E Ratio Valuation 15.4x 11.0x Lower Multiple SBC
Forward P/E Ratio Valuation N/M 9.0x Lower Multiple SBC
Revenue Growth (YoY) Growth -27.0% +35.1% Higher Growth SBC
Operating Margin (TTM) Profitability 31.7% 39.9% Higher Margin SBC
Net Profit Margin Profitability 31.7% 27.3% Higher Margin ZGM
Return on Equity (ROE) Capital Efficiency 23.4% 19.3% Higher ROE ZGM
52-Week Range Position Momentum 16% ($1โ€“$5) 52% ($3โ€“$7) Stronger Trend SBC
Beta / 30D Volatility Risk Regime 0.88ฮฒ ยท 161% Vol 0.96ฮฒ ยท 159% Vol Lower Realized Risk SBC
Unified Institutional Score Composite Signal 59.4 / 100 (HOLD) 47.2 / 100 (HOLD) Higher Composite ZGM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZGM vs SBC Buy Guide
ZGM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ZGM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SBC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SBC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZGM nor SBC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.